Stereotaxis Market Cap

Stereotaxis has a market cap or net worth of $151.32 million as of April 1, 2025. Its market cap has decreased by -26.00% in one year.

Market Cap

151.32M

Enterprise Value

145.11M

1-Year Change

-26.00%

Ranking

#3766

Market Cap Chart

Since August 12, 2004, Stereotaxis's market cap has decreased from $183.10M to $151.32M, a decrease of -17.35%. That is a compound annual growth rate of -0.92%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	154.80M	-19.88%
Dec 31, 2024	193.20M	36.54%
Dec 29, 2023	141.50M	-8.65%
Dec 30, 2022	154.90M	-66.50%
Dec 31, 2021	462.40M	23.27%
Dec 31, 2020	375.10M	6.26%
Dec 31, 2019	353.00M	474.92%
Dec 31, 2018	61.40M	237.36%
Dec 29, 2017	18.20M	28.17%
Dec 30, 2016	14.20M	-10.69%
Dec 31, 2015	15.90M	-47.52%
Dec 31, 2014	30.30M	-47.49%
Dec 31, 2013	57.70M	215.30%
Dec 31, 2012	18.30M	-55.90%
Dec 30, 2011	41.50M	-76.45%
Dec 31, 2010	176.20M	-2.22%
Dec 31, 2009	180.20M	19.97%
Dec 31, 2008	150.20M	-63.64%
Dec 31, 2007	413.10M	27.11%
Dec 29, 2006	325.00M	49.56%
Dec 30, 2005	217.30M	991.96%
Dec 31, 2004	19.90M	-89.13%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	738.61B
UnitedHealth Group	472.03B
Johnson & Johnson	394.52B
AbbVie	363.15B
Novo Nordisk	305.46B
AstraZeneca	229.16B
Abbott Laboratories	226.88B
Merck & Co.	225.40B

Market Cap Rankings